NCT03257241 2021-10-01
PALG-AML1/2016
Polish Adult Leukemia Group
Phase 3 Unknown
Clinical Trials
15 trialsNCT00558519 2021-08-18
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
Phase 2 Unknown
NCT00651261 2021-08-18
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Phase 3 Unknown
NCT01953770 2020-02-05
ALL-MB 2008
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT03390387 2020-02-05
ALL-MB 2015
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT00550992 2019-07-30
Interfant06
Dutch Childhood Oncology Group
Phase NA Unknown
NCT00449319 2017-11-17
LAM99P
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Unknown
NCT02660762 2017-06-19
Modified MRCUKALLâ…«/ECOGE2993 Regimen for ALL
Sun Yat-sen University
Phase 2 Unknown
NCT03026842 2017-01-20
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
The First Hospital of Jilin University
Phase 4 Unknown
NCT02894645 2016-09-30
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
National University Hospital, Singapore
Phase 4 Unknown
NCT02072811 2014-02-27
PALG-AML2012
Polish Adult Leukemia Group
Phase 3 Unknown
NCT00195871 2013-11-07
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
Centre Henri Becquerel
Phase 2 Unknown
NCT00111345 2012-05-23
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
University Hospital Muenster
Phase 2/3 Unknown
NCT00180128 2011-07-11
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Technische Universität Dresden
Phase 4 Unknown
NCT00131027 2008-11-14
High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)
Japan Adult Leukemia Study Group
Phase 3 Unknown